Literature DB >> 11028168

[Therapy-resistant ventricular tachycardia in a woman with primary cardiac non-Hodgkin lymphoma].

O Kohl1, H Hölschermann, H Pralle, H von Lieven, R M Bohle, J Thormann, B Waldecker.   

Abstract

HISTORY: A 65-year-old woman had suffered from relapsing ventricular tachycardias (VT) since 1996.
FINDINGS: Physical examination was normal. An arrhythmogenic substrate was found in the right ventricular outflow tract by electrophysiological examination. Nuclear magnetic resonance imaging (MRI) showed an infiltration of the right heart. Myocardial biopsy revealed a high-grade centroblastic non Hodgkin lymphoma. The patient was now transferred to our hospital for further treatment. Lactate dehydrogenase was elevated (2,030 U/l). Echocardiography showed a thickened and more reflecting right ventricular myocardium. Bone marrow aspiration and MRI/computed tomography of abdomen and thorax excluded a generalized stage. Ventricular tachycardias were caused by a primary cardiac lymphoma. TREATMENT AND COURSE: Combined radio-chemotherapy succeeded in complete remission. High-frequency ablation and amiodarone failed. Although MRI showed no more vital lymphoma after the combined radio-chemotherapy the patient suffered from spontaneous and symptomatic relapses of VT. Therefore this patient with primary cardiac lymphoma was the first in literature to get a defibrillator (ICD). The incidence of VT decreased and up to now the patient showed no relapse of the non Hodgkin lymphoma (follow-up 23 months).

Entities:  

Mesh:

Year:  2000        PMID: 11028168     DOI: 10.1007/pl00002141

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  3 in total

1.  Catheter ablation targeting Purkinje potentials controlled ventricular fibrillation in a patient with a malignant lymphoma occurring in the ventricular septum.

Authors:  Keisuke Nakabayashi; Ryo Sugiura; Toshiaki Oka
Journal:  BMJ Case Rep       Date:  2015-06-03

2.  Primary cardiac lymphoma: diagnostic tools and treatment challenges.

Authors:  R Bambury; F Gallagher; J D Dodd; D Fennelly
Journal:  Ir J Med Sci       Date:  2009-11-17       Impact factor: 1.568

3.  Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor.

Authors:  Baljit Singh; Randy Ip; Ahmed Ibrahim Al-Rajjal; Zyad Kafri; Ayad Al-Katib; Tarik Hadid
Journal:  Case Rep Cardiol       Date:  2016-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.